Table 3. Unadjusted and adjusted effects of BChE on cardiac mortality.

	Total study-cohort		Young patients (45–64a)		Middle-aged patients (65–84a)		Old patients (85–100a)
	Crude HR	p-value	Crude HR	p-value	Crude HR	p-value	Crude HR	p-value
Unadjusted Effects	0.74 (0.64–0.85)	<0.001	0.53 (0.33–0.83)	0.006	0.65 (0.65–1.10)	0.212	0.99 (0.81–1.21)	0.934
Adjusted Effects*	0.95 (0.70–1.13)	0.608	0.24 (0.12–0.61)	0.002	1.08 (0.81–1.43)	0.612	1.11 (0.89–1.38)	0.366

Cox proportional hazard model for butyrylcholinesterase in the entire cohort and age-groups. Hazard ratios (HR) for continuous variables refer to a 1-SD increase.

* The multivariate model was adjusted for gamma-GT, Quick Test, fibrinogen, age, BMI, resuscitation before angiography, hypertension, diabetes mellitus, hypercholesterinemia, positive smoking status, family history of CVD, STEMI, coronary intervention, fibrinolysis and male gender)